Ex vivo Generation of Genetically Modified Macrophages from Human Induced Pluripotent Stem Cells
Author(s) -
Mania Ackermann,
Alexandra Kuhn,
Jessica Kunkiel,
Sylvia Merkert,
Ulrich Martin,
Thomas Moritz,
Nico Lachmann
Publication year - 2017
Publication title -
transfusion medicine and hemotherapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.971
H-Index - 39
eISSN - 1660-3818
pISSN - 1660-3796
DOI - 10.1159/000477129
Subject(s) - induced pluripotent stem cell , transgene , biology , viral vector , microbiology and biotechnology , stem cell , embryonic stem cell , genetics , gene , recombinant dna
Pluripotent stem cells, including induced pluripotent stem cells (iPSCs), have the capacity to differentiate towards all three germ layers and have been highlighted as an attractive cell source for the field of regenerative medicine. Thus, stable expression of therapeutic transgenes in iPSCs, as well as thereof derived progeny of hematopoietic lineage, may lay the foundation for innovative cell replacement therapies.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom